ICD-O Morphology code. R=Rare Tier Tumour ICD-O Topography code C30.0, C31

Similar documents
incidence rate x 100,000/year

Rare cancers are those with an incidence rate 6/100,000

Layer Tumour Rate Patients 1 EPITHELIAL TUMOURS OF THE NASAL CAVITY and SINUSES Squamous cell carcinoma and variants of the Nasal Cavity

ANNUAL CANCER REGISTRY REPORT-2015

HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011

Effective January 1, 2018 ICD O 3 codes, behaviors and terms are site specific

2018 ICD-O-3 Updates in Table Format with Annotation for Reference

Effective January 1, 2018 ICD O 3 codes, behaviors and terms are site specific

ANNUAL CANCER REGISTRY REPORT-2017, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN

2 Berkeley Street, Suite 403, Toronto, Ontario M5A 2W3 Visit us at: Tel: Fax:

Other Sites. Table 2 Continued. MPH Rules 11/8/07. NAACCR Webinar Series 1

SHN-1 Human Digestive Panel Test results

ANNUAL CANCER REGISTRY REPORT-2016, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN

CANCER REGISTRY 2002

CANCER REGISTRY 2004

Methoden / Methods inc. ICCC-3 105

RARECARENet country report Bulgaria

Rare Breast Tumours. 1. Breast Tumours. 1.1 General Results. 1.2 Incidence

Appendix 4: WHO Classification of Tumours of the pancreas 17

CODING TUMOUR MORPHOLOGY. Otto Visser

S2199 S2200. * Speaker's diagnosis 78

2018 SEER Solid Tumor Manual 2018 KCR SPRING TRAINING

Vulva Inflammatory Disorders Lichen Planus Fixed Drug Eruption Erythema Multiforme Plasmacytosis Mucosae (Zoon) Lichen Sclerosus Allergic Contact

Cancer in Estonia 2014

Chapter 4. Histological groups

Cancer Association of South Africa (CANSA)

2007 Multiple Primary and

SUPPLEMENTARY INFORMATION

Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology

Quiz The main functions of the ovaries are a. To produce oocytes b. To produce estrogen c. To produce progesterone d.

RARE EPITHELIAL TUMOURS OF BREAST RARE EPITHELIAL TUMOURS OF CORPUS UTERI EPITHELIAL TUMOURS OF CERVIX UTERI

2010 Update. NAACCR Webinar Series 1 4/1/2010. Agenda. Access to 2010 Information. CSv2. Collecting Cancer Data: Soft Tissue Sarcoma

ANNUAL CANCER REGISTRY REPORT-2005

Pathology of the female genital tract

Diagnostic IHC in lung and pleura pathology

DATA STANDARDS AND QUALITY CONTROL MEMORANDUM DSQC #

Comprehensive Cancer Cover

FINALIZED SEER SINQ QUESTIONS

Differential Diagnosis of Oral Masses. Palatal Lesions

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:

3 cell types in the normal ovary

The European Commission s science and knowledge service. Joint Research Centre

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:

Oncology Centre Research Unit TUMOR REGISTRY

S Y M P O S I U M P R O G R A M

Institute of Pathology First Faculty of Medicine Charles University. Ovary

RAMATHIBODI CANCER REPORT

EPITHELIAL TUMOURS OF OESOPHAGUS RARE EPITHELIAL TUMOURS OF STOMACH EPITHELIAL TUMOURS OF SMALL INTESTINE RARE EPITHELIAL TUMOURS OF COLON

BMaP-3 Cancer Database. Aggregate Data File

CLIC Sargent Eligibility Criteria

Supplementary Online Content

Tinh hoàn

Dr Sanjiv Manek Oxford. Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust

2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill

Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013

Supplementary Information

Chapter 1 MAGNITUDE AND LEADING SITES OF CANCER

Rare Tumours of Male Genital Organs

Expression of Cytokeratin 5/6 in Epithelial Neoplasms: An Immunohistochemical Study of 509 Cases

Gynaecological Malignancies

Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence

Protocol for the Examination of Lymphadenectomy Specimens From Patients With Malignant Germ Cell and Sex Cord-Stromal Tumors of the Testis

Checklist; Anus: Excisional Biopsy Anus: Excisional Biopsy 1/1/ Checklist; Anus: Resection Anus: Resection 1/1/2005

3 cell types in the normal ovary

International Agency for Research on Cancer. World Health Organization International Association of Cancer Registries

Annual Report. Cape Cod Hospital and Falmouth Hospital Regional Cancer Network Expert physicians. Quality hospitals. Superior care.

Radiation Oncology Study Guide

Non Small Cell Lung Cancer Histopathology ד"ר יהודית זנדבנק

Salivary Glands 3/7/2017

Lesions Mimicking Adenoid Cystic Carcinoma. Diagnostic Problems in Salivary Gland Pathology An Update 5/29/2009

Epithelial Tissue. Functions include: 1. Protection 4. Absorption 2. Secretion 5. Filtration 3. Sensory reception

S2 File. Clinical Classifications Software (CCS). The CCS is a

Table of Contents. Preface xi. Acknowledgments xiii. Part I Overview of the Diagnostic Process 1. 1 Overview of Grading and Staging 3

Normal endometrium: A, proliferative. B, secretory.

Carcinoma mammario: le istologie non frequenti. Valentina Guarneri Università di Padova IOV-IRCCS

Supplementary Table S1 Glossary of preferred terms contained in the malignant or unspecified tumors SMQ narrow basket label (MedDRA version 15.

SEER Advanced Topic 2018 Presentation. EOD 2018 and SS2018 Jennifer Ruhl

4/17/2015. Case 1. A 37 year old man with a 2.2 cm solitary left thyroid mass.

List of Available TMAs in the PRN

Pathology of Ovarian Tumours. Dr. Jyothi Ranganathan MD ( Path) AFMC Pune PDCC (Cytopathology) PGI Chandigarh

Group B: Organ systems (digestive, respiratory, urinary, genital system, heart, glands and skin) green

Breast cancer: IHC classification. Mogens Vyberg Professor of Clinical Pathology Director of NordiQC Aalborg University Hospital, Aalborg, Denmark

New Developments in Immunohistochemistry for Gynecologic Pathology

Interventions for non-metastatic squamous cell carcinoma of the skin: a systematic review and pooled analysis of observational studies

* Speaker's diagnosis

FINALIZED SEER SINQ QUESTIONS April July, 2017

82330 CALCIUM; IONIZED. ICD-10 Codes that Support Medical Necessity. ICD-10 Code. Description. A15.0 Tuberculosis of lung

Endometrial adenocarcinoma icd 10 code

Tissue: The Living Fabric: Part A

Slide seminar. Asist. Prof. Jože Pižem, MD, PhD Institute of Pathology Medical Faculty, University of Ljubljana

Grade Coding Instructions and Tables

Epithelial tumors. Dr. F.F. Khuzin, PhD Dr. M.O. Mavlikeev

2018 Grade PEGGY ADAMO, RHIT, CTR OCTOBER 11, 2018

Anatomic Pathology Study Sets Glass Slides

National Cancer Intelligence Network Rare and less common cancers. Incidence and Mortality in England, 2010 to 2013

Head and Neck Squamous Subtypes

CHAPTER 4 Specific tumor sites (part 2)

Icd 10 code met renal cell

Recently, there has been an increasing incidence among women and younger persons

Transcription:

R=Rare Tier Tumour ICD-O Topography code ICD-O Morphology code EPITHELIAL TUMOURS OF NASAL CAVITY AND SINUSES R 2 Squamous cell carcinoma with variants of nasal cavity and sinuses C30.0, C3 C30.0, C3 8000, 800, 8004, 800, 80, 8020-8022, 8032, 8050-8076, 8078, 8082-8084, 823, 844, 8560, 8980 8004, 8032, 8050-8076, 8078, 8083-8084, 823, 8560, 8980 3 Squamous carcinoma C30.0, C3 8070 3 Verrucous carcinoma C30.0, C3 805 3 Squamous cell carcinoma spindle cell C30.0, C3 8004, 8032, 8074, 8980 3 Papillary squamous cell carcinoma C30.0, C3 8052 3 Adenosquamous carcinoma C30.0, C3 8560 3 Squamous cell carcinoma, adenoid C30.0, C3 8075 3 Basaloid squamous cell carcinoma C30.0, C3 8083 R 2 Lymphoepithelial carcinoma of nasal cavity and sinuses R 2 Undifferentiated carcinoma of nasal cavity and sinuses R 2 Intestinal type adenocarcinoma of nasal cavity and sinuses C30.0, C3 C30.0, C3 C30.0, C3 8082 8020-8022 844 EPITHELIAL TUMOURS OF NASOPHARYNX C 8000-800, 8004, 800-80, 8020-8022, 8032, 8050-8076, 8078, 8082-8084, 823, 8260, 8560, 8980 R 2 Squamous cell carcinoma with variants of nasopharynx C 8004, 8020-8022, 8032, 805-8076, 8078, 8082-8084, 823, 8560, 8980 3 Squamous carcinoma C 8070 3 Squamous cell carcinoma nonkeratinizing, NOS C 8072 3 Squamous cell carcinoma keratinizing, NOS C 807 3 Papillary squamous cell carcinoma C 8052 3 Basaloid squamous cell carcinoma C 8083

3 Squamous cell carcinoma, adenoid C 8075 3 Lymphoepithelial carcinoma C 8082 3 Undifferentiated carcinoma C 8020-8022 R 2 Papillary adenocarcinoma of nasopharynx C 8050, 8260 EPITHELIAL TUMOURS OF MAJOR SALIVARY GLANDS AND SALIVARY-GLAND TYPE TUMOURS R 2 Epithelial tumours of major salivary glands C7, C8 3 Squamous carcinoma C7, C8 C00-C4, C30.0, C3, C32 (For C00-C4, C30.0, C3, C32) 840, 847, 8200, 8290, 830, 8430, 8440, 8450, 8480-848, 8500, 8525, 8550, 8562, 894, 8982; (For C7, C8) 8004, 802, 8020-8022, 8032, 8050-8076, 8082, 82, 8230, 8255, 8260, 8262, 8290, 830, 8320, 8323, 840, 8940, 8980. 8004, 802, 8020-8022, 8032, 8050-8076, 8082, 840, 847, 8200, 82, 8230, 8255, 8260, 8262, 8290, 830, 8320, 8323, 840, 8430, 8440, 8450, 8480-848, 8500, 8525, 8550, 8562, 8940, 894, 8980, 8982. 8070 3 Large cell carcinoma C7, C8 802 3 Lymphoepithelial carcinoma C7, C8 8082 3 Carcinosarcoma, NOS C7, C8 8004, 8032, 8074, 8980 3 Adenocarcinoma NOS C7, C8 840 3 Clear cell adenocarcinoma, NOS C7, C8 830 3 Mucinous adenocarcinoma C7, C8 8480-848 3 Ductal carcinoma C7, C8 8500 3 Oxyphilic adenocarcinoma C7, C8 8290 3 Papillary cystadenocarcinoma, NOS C7, C8 8450 3 Adenoid cystic carcinoma C7, C8 8200 3 Mucoepidermoid carcinoma C7, C8 8430 3 Acinar cell adenocarcinoma C7, C8 8550

3 Malignant myoepithelioma C7, C8 8982 3 Carcinoma in pleomorphic adenoma C7, C8 894 3 Mixed tumour, malignant C7, C8 8940 3 Polymorphous low grade adenocarcinoma C7, C8 8525 3 Basal cell adenocarcinoma C7, C8 847 3 Epithelial-myoepithelial carcinoma C7, C8 8562 3 Sebaceous adenocarcinoma C7, C8 840 3 Cystadenocarcinoma, NOS C7, C8 8440 3 Low grade cribriform cystadenocarcinoma C7, C8 malignancy without ICD-O morphology code R 2 Salivary gland type tumours of head and neck C00-C06, C09-C4, C30.0, C3, C32 3 Mucoepidermoid carcinoma C00-C06, C09-C4, C30.0, C3, C32 3 Adenocarcinoma NOS C00-C06, C09-C4, C30.0, C3, C32 3 Adenoid cystic carcinoma C00-C06, C09-C4, C30.0, C3, C32 3 Acinar cell adenocarcinoma C00-C06, C09-C4, C30.0, C3, C32 3 Ductal carcinoma C00-C06, C09-C4, C30.0, C3, C32 3 Mucinous adenocarcinoma C00-C06, C09-C4, C30.0, C3, C32 3 Basal cell adenocarcinoma C00-C06, C09-C4, C30.0, C3, C32 3 Clear cell adenocarcinoma, NOS C00-C06, C09-C4, C30.0, C3, C32 3 Epithelial-myoepithelial carcinoma C00-C06, C09-C4, C30.0, C3, C32 3 Polymorphous low grade adenocarcinoma C00-C06, C09-C4, C30.0, C3, C32 840, 847, 8200, 8290, 830, 8430, 8440, 8450, 8480-848, 8500, 8525, 8550, 8562, 894, 8982 8430 840 8200 8550 8500 8480-848 847 830 8562 8525

3 Carcinoma in pleomorphic adenoma C00-C06, C09-C4, C30.0, C3, C32 3 Malignant myoepithelioma C00-C06, C09-C4, C30.0, C3, C32 3 Cystadenocarcinoma, NOS C00-C06, C09-C4, C30.0, C3, C32 3 Oncocytic carcinoma C00-C06, C09-C4, C30.0, C3, C32 3 Papillary cystadenocarcinoma, NOS C00-C06, C09-C4, C30.0, C3, C32 894 8982 8440 8290 8450 EPITHELIAL TUMOURS OF HYPOPHARYNX AND LARYNX R 2 Squamous cell carcinoma with variants of hypopharynx C2, C3, C32 C2, C3 8000-800, 8004, 800-80, 8020-8022, 803-8032, 8050-8076, 8078, 8082-8084, 823, 8560, 8980 8004, 8020-8022, 803-8032, 8050-8076, 8078, 8082-8084, 823, 8560, 8980 3 Squamous carcinoma C2, C3 8070 3 Lymphoepithelial carcinoma C2, C3 8082 3 Verrucous carcinoma C2, C3 805 3 Squamous cell carcinoma spindle cell C2, C3 8004, 8032, 8074, 8980 3 Giant cell carcinoma C2, C3 803 3 Adenosquamous carcinoma C2, C3 8560 3 Squamous cell carcinoma, adenoid C2, C3 8075 3 Undifferentiated carcinoma C2, C3 8020-8022 3 Papillary squamous cell carcinoma C2, C3 8052 3 Basaloid squamous cell carcinoma C2, C3 8083 R 2 Squamous cell carcinoma with variants of larynx C32 8004, 8020-8022, 803-8032, 8050-8076, 8078, 8082-8084, 823, 8560, 8980 3 Squamous carcinoma C32 8070 3 Verrucous carcinoma C32 805

3 Squamous cell carcinoma spindle cell C32 8004, 8074, 8032, 8980 3 Papillary squamous cell carcinoma C32 8052 3 Adenosquamous carcinoma C32 8560 3 Squamous cell carcinoma, adenoid C32 8075 3 Undifferentiated carcinoma C32 8020-8022 3 Lymphoepithelial carcinoma C32 8082 3 Giant cell carcinoma C32 803 3 Basaloid squamous cell carcinoma C32 8083 EPITHELIAL TUMOURS OF OROPHARYNX C0.9, C02.4, C02.8, C05.- C05.2, C05.9, C09.0-C0.3, C0.8-0.9, C4.2 R 2 Squamous cell carcinoma with variants of oropharynx C0.9, C02.4, C02.8, C05.- C05.2, C05.9, C09.0-C0.3, C0.8-0.9, C4.2 3 Squamous carcinoma C0.9, C02.4, C02.8, C05.- C05.2, C05.9, C09.0-C0.3, C0.8-0.9, C4.2 3 Lymphoepithelial carcinoma C0.9, C02.4, C02.8, C05.- C05.2, C05.9, C09.0-C0.3, C0.8-0.9, C4.2 3 Verrucous carcinoma C0.9, C02.4, C02.8, C05.- C05.2, C05.9, C09.0-C0.3, C0.8-0.9, C4.2 3 Squamous cell carcinoma spindle cell C0.9, C02.4, C02.8, C05.- C05.2, C05.9, C09.0-C0.3, C0.8-0.9, C4.2 3 Papillary squamous cell carcinoma C0.9, C02.4, C02.8, C05.- C05.2, C05.9, C09.0-C0.3, C0.8-0.9, C4.2 3 Squamous cell carcinoma, adenoid C0.9, C02.4, C02.8, C05.- C05.2, C05.9, C09.0-C0.3, C0.8-0.9, C4.2 3 Basaloid squamous cell carcinoma C0.9, C02.4, C02.8, C05.- C05.2, C05.9, C09.0-C0.3, C0.8-0.9, C4.2 3 Adenosquamous carcinoma C0.9, C02.4, C02.8, C05.- C05.2, C05.9, C09.0-C0.3, C0.8-0.9, C4.2 3 Undifferentiated carcinoma C0.9, C02.4, C02.8, C05.- C05.2, C05.9, C09.0-C0.3, C0.8-0.9, C4.2 EPITHELIAL TUMOURS OF ORAL CAVITY AND LIP C00.0-C00.9 C02.0-C02.3, C02.9, C03.0-C05.0, C06.0- C06.9 8000-800, 8004, 800-80, 8020-8022, 8032, 8050-8076, 8078, 8082-8084, 823, 8560, 8980 8004, 8020-8022, 8032, 8050-8076, 8078, 8082-8084, 823, 8560, 8980 8070 8082 805 8004, 8032, 8074, 8980 8052 8075 8083 8560 8020-8022 8000-800, 8004, 800-80, 8020-8022, 8032, 8050-8076, 8078, 8082-8084, 823, 8560, 8980

R 2 Squamous cell carcinoma with variants of oral cavity C02.0-C02.3, C02.9, C03.0- C05.0, C06.0-C06.9 8004, 8020-8022, 8032, 8050-8076, 8078, 8082-8084, 823, 8560, 8980 3 Squamous carcinoma C02.0-C02.3, C02.9, C03.0- C05.0, C06.0-C06.9 3 Verrucous carcinoma C02.0-C02.3, C02.9, C03.0- C05.0, C06.0-C06.9 3 Squamous cell carcinoma spindle cell C02.0-C02.3, C02.9, C03.0- C05.0, C06.0-C06.9 3 Adenosquamous carcinoma C02.0-C02.3, C02.9, C03.0- C05.0, C06.0-C06.9 3 Papillary squamous cell carcinoma C02.0-C02.3, C02.9, C03.0- C05.0, C06.0-C06.9 3 Squamous cell carcinoma, adenoid C02.0-C02.3, C02.9, C03.0- C05.0, C06.0-C06.9 3 Basaloid squamous cell carcinoma C02.0-C02.3, C02.9, C03.0- C05.0, C06.0-C06.9 3 Lymphoepithelial carcinoma C02.0-C02.3, C02.9, C03.0- C05.0, C06.0-C06.9 3 Undifferentiated carcinoma C02.0-C02.3, C02.9, C03.0- C05.0, C06.0-C06.9 R 2 Squamous cell carcinoma with variants of lip C00.0-C00.9 8070 805 8004, 8032, 8074, 8980 8560 8052 8075 8083 8082 8020-8022 8004, 8032, 8050-8076, 8078, 8082-8084, 8560, 8980 3 Squamous carcinoma C00.0-C00.9 8070 EPITHELIAL TUMOURS OF OESOPHAGUS C5 R 2 Squamous cell carcinoma with variants of oesophagus C5 3 Squamous carcinoma C5 8000-800, 8004, 800-80, 8020-8022, 8032, 8050-8076, 8078, 8082-8084, 840-84, 843, 847, 890, 8200-820, 820-82, 822, 8230-823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 840, 8430, 8440-844, 8450, 8480-8482, 8490, 8500, 8503-8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562, 857-8576, 8980 8004, 8032, 8050-8076, 8078, 8082-8084, 8560, 8980 8070 3 Adenosquamous carcinoma C5 8560 3 Squamous cell carcinoma spindle cell C5 8004, 8032, 8074, 8980 3 Verrucous carcinoma C5 805 3 Papillary squamous cell carcinoma C5 8052

3 Basaloid squamous cell carcinoma C5 8083 3 Squamous cell carcinoma, adenoid C5 8075 R 2 Adenocarcinoma with variants of oesophagus C5 R 2 Salivary gland type tumours of oesophagus C5 840-84, 843, 847, 890, 820, 820-82, 822, 8230-823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 840, 8440-844, 8450, 8480-8482, 8490, 8500, 8503-8504, 850, 852, 854, 8525, 8542, 855, 857-8576 8200, 8430, 8550, 8562 3 Mucoepidermoid carcinoma C5 8430 3 Adenoid cystic carcinoma C5 8200 R 2 Undifferentiated carcinoma of oesophagus C5 8020-8022 EPITHELIAL TUMOURS OF STOMACH C6 2 Adenocarcinoma with variants of stomach C6 3 Adenocarcinoma NOS C6 8000-800, 8004, 800-80, 8020-8022, 8032, 8050-8076, 8078, 8082-8084, 840-845, 847, 890, 8200-820, 820-82, 824, 822, 8230-823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 840, 8430, 8440-844, 8450, 8480-8482, 8490, 8500, 8503-8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562, 857-8576, 8980 8050, 840-845, 847, 890, 820, 820-82, 824, 822, 8230-823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 840, 8440-844, 8450, 8480-8482, 8490, 8500, 8503-8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562, 857-8576 840 3 Adenocarcinoma intestinal type C6 844 3 Signet ring cell carcinoma C6 8490 3 Carcinoma diffuse type C6 845 3 Mucinous adenocarcinoma C6 8480-848 3 Tubular adenocarcinoma C6 82 3 Papillary adenocarcinoma, NOS C6 8050, 8260 3 Adenosquamous carcinoma C6 8560

R 2 Squamous cell carcinoma with variants of stomach C6 8004, 8032, 805-8076, 8078, 8082-8084, 8980 3 Squamous carcinoma C6 8070 3 Squamous cell carcinoma spindle cell C6 8004, 8032, 8074, 8980 3 Basaloid carcinoma C6 8083 3 Verrucous carcinoma C6 805 3 Squamous cell carcinoma, adenoid C6 8075 3 Papillary squamous cell carcinoma C6 8052 R 2 Salivary gland-type tumours of stomach C6 8200, 8430 3 Mucoepidermoid carcinoma C6 8430 3 Adenoid cystic carcinoma C6 8200 R 2 Undifferentiated carcinoma of stomach C6 8020-8022 EPITHELIAL TUMOURS OF SMALL INTESTINE C7 R 2 Adenocarcinoma with variants of small intestine C7 3 Adenocarcinoma NOS C7 8000-800, 8004, 800-80, 8020-8022, 8032, 8050-8076, 8078, 8082-8084, 840-84, 843, 847, 890, 820, 820-82, 822, 8230-823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 840, 8430, 8440-844, 8450, 8480-8482, 8490, 8500, 8503-8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562, 857-8576, 8980 8020-8022, 840-84, 843, 847, 890, 820, 820-82, 822, 8230-823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 840, 8430, 8440-844, 8450, 8480-8482, 8490, 8500, 8503-8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562, 857-8576 840 3 Mucinous adenocarcinoma C7 8480-848 3 Signet ring cell carcinoma C7 8490 3 Adenosquamous carcinoma C7 8560 3 Medullary carcinoma, NOS C7 850

3 Undifferentiated carcinoma C7 8020-8022 R 2 Squamous cell carcinoma with variants of small intestine C7 8004, 8032, 8050-8076, 8078, 8082-8084, 8980 3 Squamous carcinoma C7 8070 EPITHELIAL TUMOURS OF COLON C8, C9 2 Adenocarcinoma with variants of colon C8, C9 8000-800, 8004, 800-80, 8020-8022, 8032, 8050-8076, 8078, 8082-8084, 840-84, 843, 847, 890, 820, 820-82, 8220-822, 8230-823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 840, 8430, 8440-844, 8450, 8480-8482, 8490, 8500, 8503-8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562, 857-8576, 8980 8020-8022, 840-84, 843, 847, 890, 820, 820-82, 8220-822, 8230-823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 840, 8430, 8440-844, 8450, 8480-848 (only in C8.0, 82-89, C9), 8482, 8490, 8500, 8503-8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562, 857-8576 3 Adenocarcinoma NOS C8, C9 840 3 Mucinous adenocarcinoma C8.0,8.2-8.9, C9 (NOT in C8.) 8480/3-848 3 Signet ring cell carcinoma C8, C9 8490 3 Adenosquamous carcinoma C8, C9 8560 3 Undifferentiated carcinoma C8, C9 8020-8022 3 Medullary carcinoma, NOS C8, C9 850 R 2 Squamous cell carcinoma with variants of colon C8, C9 8004, 8032, 8050-8076, 8078, 8082-8084, 8980 2 Fibromixoma and low grade mucinous C8. adenocarcinoma (pseudomixoma peritonei) of the appendix EPITHELIAL TUMOURS OF RECTUM C20 2 Adenocarcinoma with variants of rectum C20 8480-848 8000-800, 8004, 800-80, 8020-8022, 8032, 8050-8076, 8078, 8082-8084, 823-824, 840-84, 843, 847, 890, 820, 820-82, 8220-822, 8230-823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 840, 8430, 8440-844, 8450, 8480-8482, 8490, 8500, 8503-8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562, 857-8576, 8980 8020-8022, 840-84, 843, 847, 890, 820, 820-82, 8220-822, 8230-823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 840, 8430, 8440-844, 8450, 8480-8482, 8490, 8500, 8503-8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562, 857-8576

3 Adenocarcinoma NOS C20 840 3 Mucinous adenocarcinoma C20 8480-848 3 Signet ring cell carcinoma C20 8490 3 Adenosquamous carcinoma C20 8560 3 Undifferentiated carcinoma C20 8020-8022 3 Medullary carcinoma, NOS C20 850 R 2 Squamous cell carcinoma with variants of rectum C20 8004, 8032, 8050-8076, 8078, 8082-8084, 823-824, 8980 3 Verrucous carcinoma C20 805 3 Basaloid carcinoma of rectum C20 823-824 2 Basaloid carcinoma of rectum C20 823-824 EPITHELIAL TUMOURS OF ANAL CANAL C2 R 2 Squamous cell carcinoma with variants of anal canal C2 3 Verrucous carcinoma C2 8000-800, 8004, 800-80, 8020-8022, 8032, 8050-8076, 8078, 8082-8084, 823-824, 840-84, 843, 847, 890, 820, 820-82, 825, 822, 8230-823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 840, 8430, 8440-844, 8450, 8480-8482, 8490, 8500, 8503-8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562, 857-8576, 8980 8004, 8020-8022, 8032, 8050-8076, 8078, 8082-8084, 8980, 823-824 805 3 Undifferentiated carcinoma C2 8020-8022 3 Basaloid carcinoma of anal canal C2 823-824 R 2 Adenocarcinoma with variants of anal canal C2 3 Mucinous adenocarcinoma C2 840-84, 843, 847, 890, 820, 820-82, 825, 822, 8230-823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 840, 8430, 8440-844, 8450, 8480-8482, 8490, 8500, 8503-8504, 850, 852, 854, 8525, 8550-855, 8560, 8562, 857-8576 8480-848 R 2 Paget's disease of anal canal C2 8542

EPITHELIAL TUMOURS OF PANCREAS C25 2 Adenocarcinoma with variants of pancreas C25 3 Adenocarcinoma NOS C25 8000-800, 8004, 800-80, 8020-8022, 8032, 8035, 8050-8076, 8078, 8082-8084, 840-84, 843, 847, 890, 820, 820-82, 822, 8230-823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 8430, 8440-844, 8450, 8452-8453, 8470, 8480-8482, 8490, 8500, 8503-8504, 850, 852, 8548525, 8542, 8550-855, 8560, 8562, 857-8576, 8980 800, 8020-8022, 840-84, 843, 847, 890, 820, 820-82, 822, 8230-823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 8430, 8440, 8450, 8480-8482, 8490, 8500, 8503-8504, 850, 852, 854, 8525, 8542, 855, 8560, 8562, 857-8576 840 3 Mucinous adenocarcinoma C25 8480-848 3 Undifferentiated carcinoma C25 8020-8022 3 Signet ring cell carcinoma C25 8490 3 Adenosquamous carcinoma C25 8560 R 2 Squamous cell carcinoma with variants of pancreas C25 8004, 8032, 8050-8076, 8078, 8082-8084, 8980 R 2 Acinar cell carcinoma of pancreas C25 8550 R 2 Mucinous cystadenocarcinoma of pancreas C25 8470 R 2 Intraductal papillary mucinous carcinoma invasive of pancreas C25 8453 R 2 Solid pseudopapillary carcinoma of pancreas C25 8452 R 2 Serous cystadenocarcinoma of pancreas C25 844 R 2 Carcinoma with osteoclast-like giant cells of pancreas C25 8035 EPITHELIAL TUMOURS OF LIVER AND INTRAEPATIC BILE TRACT (IBT) C22 8000-800, 8004, 800-80, 8020-8022, 8032, 805-8076, 8078, 8082-8084, 840-84, 843, 847, 860-862, 870-875, 880, 890, 820, 820-82, 822, 8230-823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 8430, 8440-844, 8450, 8480-8482, 8490, 8500, 8503-8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562, 857-8576, 8980 R 2 Hepatocellular carcinoma of Liver and IBT C22 870, 872-875, 880

3 Combined hepatocellular carcinoma and cholangiocarcinoma C22 880 3 Hepatocellular carcinoma, fibrolamellar C22 87 R 2 Hepatocellular carcinoma, fibrolamellar C22 87 R 2 Cholangiocarcinoma of IBT C22 860 R 2 Adenocarcinoma with variants of liver and IBT C22 R 2 Undifferentiated carcinoma of liver and IBT C22 840-84, 843, 847, 862, 890, 820, 820-82, 822, 8230-823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 8430, 8440-844, 8450, 8480-8482, 8490, 8500, 8503-8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562, 857-8576 8020-8022 R 2 Squamous cell carcinoma with variants of liver and IBT C22 8004, 8032, 805-8076, 8078, 8082-8084, 8980 2 Bile duct cystadenocarcinoma of IBT C22 86 EPITHELIAL TUMOURS OF GALLBLADDER AND EXTRAHEPATIC BILIARY TRACT (EBT) R 2 Adenocarcinoma with variants of gallbladder and EBT C23, C24 C23 8000-800, 8004, 800-80, 8020-8022, 8032, 8050-8076, 8078, 8082-8084, 840-84, 843, 844, 847, 860-862, 890, 820, 820-82, 822, 8230-823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 8430, 8440-844, 8450, 8480-8482, 8490, 8500, 8503-8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562, 857-8576, 8980 8020-8022, 8050, 840-84, 843, 844, 847, 860-862, 890, 820, 820-82, 822, 8230-823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 8430, 8440-844, 8450, 8480-8482, 8490, 8500, 8503-8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562, 857-8576 3 Cholangiocarcinoma C23 860 3 Papillary adenocarcinoma, NOS C23 8050, 8260 3 Adenocarcinoma intestinal type C23 844 3 Mucinous adenocarcinoma C23 8480-848 3 Clear cell adenocarcinoma, NOS C23 830 3 Signet ring cell carcinoma C23 8490

3 Adenosquamous carcinoma C23 8560 3 Undifferentiated carcinoma C23 8020-8022 3 Bile duct cystadenocarcinoma C23 86 R 2 Adenocarcinoma with variants of gallbladder and EBT C23, C24 8020-8022, 8050, 840-84, 843, 844, 847, 860-862, 890, 820, 820-82, 822, 8230-823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 8430, 8440-844, 8450, 8480-8482, 8490, 8500, 8503-8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562, 857-8576 3 Cholangiocarcinoma C23, C24 860 3 Papillary adenocarcinoma, NOS C23, C24 8050, 8260 3 Adenocarcinoma intestinal type C23, C24 844 3 Mucinous adenocarcinoma C23, C24 8480-848 3 Clear cell adenocarcinoma, NOS C23, C24 830 3 Signet ring cell carcinoma C23, C24 8490 3 Adenosquamous carcinoma C23, C24 8560 3 Undifferentiated carcinoma C23, C24 8020-8022 3 Bile duct cystadenocarcinoma C23, C24 86 R 2 Squamous cell carcinoma of gallbladder and EBT C23, C24 8004, 8032, 805-8076, 8078, 8082-8084, 8980 EPITHELIAL TUMOUR OF TRACHEA C33 R 2 Squamous cell carcinoma with variants of trachea C33 8000-800, 8004, 800-80, 8044, 8020-8022, 803-8032, 8050-8076, 8078, 8082-8084, 840-84, 843-844, 847, 890, 8200-820, 820-82, 822, 8230-823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 8430, 8440-844, 8470, 8480-8482, 8490, 8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562-8576, 8980, 8982 8004, 8020-8022, 803-8032, 8050-8076, 8078, 8082-8084, 8560, 8980 3 Squamous carcinoma C33 8070

3 Papillary squamous cell carcinoma C33 8052 3 Basaloid squamous cell carcinoma C33 8083 3 Squamous cell carcinoma clear cell type C33 8084 3 Verrucous carcinoma C33 805 3 Squamous cell carcinoma, adenoid C33 8075 3 Spindle cell carcinoma C33 8004, 8032, 8074, 8980 3 Adenosquamous carcinoma C33 8560 3 Lymphoepithelial carcinoma C33 8082 3 Giant cell carcinoma C33 803 3 Undifferentiated carcinoma C33 8020-8022 R 2 Adenocarcinoma with variants of trachea C33 3 Adenocarcinoma NOS C33 840-84, 843, 844, 847, 890, 820, 820-82, 822, 8230, 823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 8440-844, 8470, 8480-8482, 8490, 8504, 850, 852, 854, 8525, 8542, 8550-855, 8562-8576 840 3 Mucinous adenocarcinoma C33 8480-848 3 Papillary adenocarcinoma, NOS C33 8260 3 Solid carcinoma, NOS C33 8230 3 Clear cell adenocarcinoma, NOS C33 830 3 Acinar cell adenocarcinoma C33 8550 3 Signet ring cell carcinoma C33 8490 3 Mucinous cystadenocarcinoma, NOS C33 8470

R 2 Salivary gland type tumours of trachea C33 8200, 8430, 8982 3 Adenoid cystic carcinoma C33 8200 3 Mucoepidermoid carcinoma C33 8430 3 Myoepithelial carcinoma C33 8982 EPITHELIAL TUMOUR OF LUNG C34 8000-800, 8004, 800-804, 8020-802, 8032, 8034, 804-8046, 8050-8084, 823, 840-84, 843, 844, 847, 890, 8200-820, 820-82, 822, 8230, 823, 8240-8245,- 8246, 8249-8254 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 8430, 8440-844, 8460, 8470, 8480-8482, 8490, 8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562-8576, 8972, 8980, 8982 2 Squamous cell carcinoma with variants of lung C34 8050-8070, 8073, 8075-8084 3 Squamous carcinoma C34 8070 3 Papillary squamous cell carcinoma C34 8052 3 Basaloid squamous cell carcinoma C34 8083 3 Squamous cell carcinoma small cell nonkeratinizing C34 8073 3 Squamous cell carcinoma clear cell type C34 8084 2 Adenocarcinoma with variants of lung C34 3 Adenocarcinoma NOS C34 840-84, 843, 844, 847, 890, 820, 820-82, 822, 8230, 823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 8440-844, 8460, 8470, 8480-8482, 8490, 8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562-8576 840 3 Mucinous adenocarcinoma C34 8480-848 3 Papillary adenocarcinoma, NOS C34 8260 3 Solid carcinoma, NOS C34 8230 3 Clear cell adenocarcinoma, NOS C34 830

3 Acinar cell adenocarcinoma C34 8550 3 Signet ring cell carcinoma C34 8490 3 Adenosquamous carcinoma C34 8560 3 Mucinous cystadenocarcinoma, NOS C34 8470 3 Adenocarcinoma with mixed subtypes C34 8255 3 Fetal adenocarcinoma C34 8333 R 2 Large cell carcinoma of lung C34 802, 8034, 807-72, 823 R 2 Atypical carcinoid of lung C34 8240-8246, 8249 2 Poorly differentiated endocrine carcinoma of lung C34 803, 804-8045, 8246 3 Small cell endocrine carcinoma of the lung C34 804-8045 3 Large cell endocrine carcinoma of the lung C34 803 R 2 Bronchiolo-alveolar carcinoma of lung C34 8250-8254 3 Bronchiolo-alveolar carcinoma, mucinous C34 8253 3 Bronchiolo-alveolar carcinoma, non mucinous C34 8252 3 Bronchiolo-alveolar carcinoma, mixed mucinous and non-mucinous C34 8254 R 2 Salivary gland type tumours of lung C34 8200, 8430, 8982 3 Adenoid cystic carcinoma C34 8200 3 Mucoepidermoid carcinoma C34 8430 3 Myoepithelial carcinoma C34 8982 R 2 Sarcomatoid carcinoma of lung C34 8004, 8022, 8030-8033, 8074, 8980, 8972

3 Sarcomatoid carcinoma C34 8033 3 Pleomorphic carcinoma C34 8022 3 Giant cell carcinoma C34 803 3 Carcinosarcoma, NOS C34 8980 3 Spindle cell carcinoma C34 8004, 8032, 8074 3 Pulmonary blastoma C34 8972 R 2 Undifferentiated carcinoma of lung C34 8020-802 EPITHELIAL TUMOURS OF THYMUS C37 R 2 Malignant thymoma C37 8000-800, 800-80, 8020-8022, 8032, 8050-8076, 8078, 8082-8084, 823, 840-84, 843-844, 847, 890, 8200-820, 820-82, 822, 8230-823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 8430, 8440-844, 8480-8482, 8490, 8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562-8576, 8580-8586 8580-8586 3 Thymoma, malignant, NOS C37 8580 3 Malignant thymoma, type AB C37 8582 3 Malignant thymoma, type A C37 858 3 Malignant thymoma, type B C37 8583, 8584, 8585 3 Malignant thymoma, type C C37 8586 R 2 Squamous cell carcinoma of thymus C37 805-8076, 8078, 8083-8084, 823 R 2 Undifferentiated carcinoma of thymus C37 8020-8022 R 2 Lymphoepithelial carcinoma of thymus C37 8082 R 2 Adenocarcinoma with variants of thymus C37 8050, 840-84, 843, 844, 847, 890, 8200-820, 820-82, 822, 8230, 823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 8430, 8440-844, 8480-8482, 8490, 8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562-8576

3 Adenocarcinoma NOS C37 840 3 Papillary adenocarcinoma, NOS C37 8050, 8260 EPITHELIAL TUMOURS OF BREAST C50 2 Invasive ductal carcinoma of breast C50 8000-800, 800-80, 8022, 8070, 840-84, 843, 847, 890, 8200-820, 820-82, 822, 8230-823, 8255, 8260-8263, 8290, 830, 834-835, 8320, 8323, 8333, 8380-8384, 840, 8430, 8480-8482, 8490, 8500-8504, 8508, 850, 852-854, 8520-8525, 8530, 8540-854, 8543, 8550-855, 8560, 8562, 8570-8576, 8982 820, 8500, 850, 8503, 854, 852, 8523 2 Invasive lobular carcinoma of breast C50 8022,8520, 8524 3 Classic type C50 8520 3 Pleomorphic carcinoma C50 8022 R 2 Mammary Paget s disease of breast C50 8540, 854, 8543 R 2 Special types of adenocarcinoma of breast C50 3 Tubular adenocarcinoma C50 8050, 820, 82, 8260, 8290, 834-835, 840, 8480-848, 8502, 850 82 3 Mucinous carcinoma C50 8480-848 3 Medullary carcinoma, NOS C50 850 3 Papillary adenocarcinoma, NOS C50 8050, 8260 3 Cribriform carcinoma C50 820 3 Apocrine adenocarcinoma C50 840 3 Secretory carcinoma C50 8502 3 Glycogen-rich clear cell carcinoma C50 835 3 Lipid-rich carcinoma C50 834 3 Oncocytic carcinoma C50 8290

R 2 Metaplastic carcinoma of breast C50 8070, 8560, 857, 8572, 8575 3 Squamous carcinoma C50 8070 3 Adenosquamous carcinoma C50 8560 3 Adenocarcinoma with cartilaginous and osseous metaplasia C50 857 3 Adenocarcinoma with spindle cell metaplasia C50 8572 R 2 Salivary gland type tumours of breast C50 8200, 8430, 8550, 8982 3 Mucoepidermoid carcinoma C50 8430 3 Adenoid cystic carcinoma C50 8200 3 Myoepithelial carcinoma C50 8982 3 Acinar cell adenocarcinoma C50 8550 R 2 Epithelial tumour of male breast C50 EPITHELIAL TUMOURS OF CORPUS UTERI C54 8000-800, 800-80, 8022, 8070, 840-84, 843, 847, 890, 8200-820, 820-82, 822, 8230-823, 8255, 8260-8263, 8290, 830, 834-835, 8320, 8323, 8333, 8380-8384, 840, 8430, 8480-8482, 8490, 8500-8504, 8508, 850, 852-854, 8520-8525, 8530, 8540-854, 8543, 8550-855, 8560, 8562, 8570-8576, 8982 8000, 800, 800, 80, 8070-8078, 8082-8084, 820, 822, 823, 840-84, 843, 844, 847, 890, 8200, 820, 820-82, 822, 8230, 823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 8430, 8440-844, 8480-8482, 8490, 8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562-8576, 8950-895, 8980, 9000, 90 2 Adenocarcinoma with variants of corpus uteri C54 3 Adenocarcinoma, NOS C54 820, 822, 823, 840-84, 843, 844, 847, 890, 820, 820-82, 822, 8230, 823, 8255, 8260-8263, 8290, 835, 8320, 8323, 8333, 8380-8384, 8430, 8440, 8460, 8480-8482, 8490, 8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562-8576, 9000, 90 840 3 Endometrioid adenocarcinoma, NOS C54 8380 3 Adenosquamous carcinoma C54 8560

3 Mucinous adenocarcinoma C54 8480-848 3 Mixed cell adenocarcinoma C54 8323 3 Endometrioid adenocarcinoma secretory variant C54 8382 3 Villous adenocarcinoma C54 8262 3 Brenner tumor, malignant 9000 3 Transitional cell carinoma 820 3 Transitional cell ca spindle cell 822 3 Basaloid carcinoma 823 3 Endometrioid adenocarcinoma ciliated cell variant R 2 Squamous cell carcinoma with variants of corpus uteri C54 C54 8383 8070-8078, 8082-8084 R 2 Adenoid cystic carcinoma of corpus uteri C54 8200 2 Clear cell adenocarcinoma, NOS C54 830 2 Serous (papillary) carcinoma C54 844 R 2 Mullerian mixed tumour C54 8950, 895,8980 2 Small cell carcinoma NET new morphology. ICD-O code not available EPITHELIAL TUMOURS OF CERVIX UTERI C53 R 2 Squamous cell carcinoma with variants of cervix uteri C53 3 Squamous carcinoma C53 8000, 800, 800, 80, 805, 8020-8022, 8032, 8050-8084, 820, 823, 840-84, 843, 844, 847, 890, 8200-820, 820-82, 822, 8230, 823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 8430, 8440-844, 8480-8482, 8490, 8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562-8576, 8950-895, 8980, 90 805, 820, 823, 8050-8084 8070

3 Squamous cell carcinoma nonkeratinizing, NOS C53 8072 3 Squamous cell carcinoma keratinizing, NOS C53 807 3 Papillary squamous cell carcinoma C53 8052 3 Papillary carcinoma, NOS C53 8050 3 Verrucous/Warty carcinoma C53 805 3 Basaloid carcinoma C53 823 3 Squamous cell carcinoma spindle cell C53 8074 3 Lymphoepithelial carcinoma C53 8082 3 Transitional cell carcinoma, NOS C53 820 3 Glassy cell carcinoma C53 805 R 2 Adenocarcinoma with variants of cervix uteri C53 3 Adenocarcinoma, NOS C53 840-84, 843, 844, 847, 890, 8200-820, 820-82, 822, 8230, 823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 8430, 8440-844, 8460, 8480-8482, 8490, 8504, 850, 852, 854, 8525, 8542, 8550-855,8562-8576, 90 840 3 Adenocarcinoma with squamous metaplasia C53 8570 3 Mucinous adenocarcinoma C53 8480-848 3 Clear cell adenocarcinoma, NOS C53 830 3 Endometrioid adenocarcinoma, NOS C53 8380 3 Serous cystadenocarcinoma, NOS C53 844 3 Signet ring cell carcinoma C53 8490 3 Mesonephroma malignant C53 90

3 Villous adenocarcinoma C53 8262 3 Mucinous adenocarcinoma, endocervical type C53 8482 3 Adenocarcinoma intestinal type C53 844 3 Mixed cell adenocarcinoma C53 8323 R 2 Undifferentiated carcinoma of cervix uteri C53 8020-8022 R 2 Mullerian mixed tumour of cervix uteri C53 8950, 895,8980 2 Small cell carcinoma NET new morphology. ICD-O code not available MIXED EPITHELIAL AND MESENCHYMAL TUMOURS OF UTERUS C53.0-C55.9 8933, 8950-895, 8980 3 Mullerian mixed tumour C53.0-C55.9 8950, 8980 3 Adenosarcoma C53.0-C55.9 8933 EPITHELIAL TUMOURS OF OVARY AND FALLOPIAN TUBE C56.9, C57.0-C57.3 8000, 800, 800, 80, 8050, 820, 822, 823, 840-84, 843, 847, 890, 8200-820, 820-82, 822, 8230, 823, 8255, 8260-8263, 8290, 833, 833, 835, 8320, 8323, 8333, 8380-8384, 8430, 8440-8463, 8470-8490, 8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562-8576, 8950-895, 8980, 9000, 904-905, 90 (and 8050, 8260, 844, 8450, 8460, 846 in C48) R 2 Adenocarcinoma with variants of ovary C56.9 3 Serous (papillary) cystadenocarcinoma C56.9 8050, 820, 822, 823, 840-84, 843, 847, 890, 8200-820, 820-82, 823, 8255, 8260-8263, 8290, 833, 835, 8320, 822, 8230, 8323, 8333, 8380-8384, 8430, 8440-8463, 8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562-8576, 9000, 904-905, 90 844, 8460, 846 3 Adenocarcinoma NOS C56.9 840 3 Endometrioid adenocarcinoma, NOS C56.9 8380 3 Papillary adenocarcinoma, NOS C56.9 8050, 8260, 8450 3 Endometrioid adenofibroma malignant C56.9 838

3 Clear cell adenocarcinofibroma C56.9 833 3 Serous adenocarcinofibroma C56.9 904 3 Mucinous adenocarcinofibroma C56.9 905 3 Brenner tumor, malignant C56.9 9000 3 Transitionalcell carinoma C56.9 820 3 Transitional cell ca spindle cell C56.9 822 3 Basoloid carcinoma C56.9 823 R 2 Mucinous adenocarcinoma of ovary C56.9 8470-8490 R 2 Clear cell adenocarcinoma of ovary C56.9 830 2 Primary peritoneal serous/papillary carcinoma C48 8050, 8260, 844, 8450, 8460, 846 R 2 Mullerian mixed tumour of ovary C56.9 8950, 895, 8980 2 Small cell NET new morphology. ICD-O code not available R 2 Adenocarcinoma with variants of fallopian tube C57.0-C57.3 3 Adenocarcinoma NOS C57.0-C57.3 8050, 840-84, 843, 847, 890, 8200-820, 820-82, 822, 8230, 823, 8255, 8260-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 8430, 8440-844, 8460, 8480-8482, 8490, 8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562-8576, 904-905, 90 840 3 Papillary serous cystadenocarcinoma C57.0-C57.3 8460 3 Serous cystadenocarcinoma, NOS C57.0-C57.3 844 3 Papillary adenocarcinoma, NOS C57.0-C57.3 8050, 8260 NON EPITHELIAL TUMOURS OF OVARY C56 8600, 8620, 8630-863, 8634, 8640, 8650, 8670, 8933, 8950-895, 8980, 9060-9065, 9070-9072, 9080-9085, 9090, 900-902, 939, 9440, 9473, 950

R 2 Mixed epithelial/mesenchymal tumours of ovary 3 Mullerian mixed tumour (become tier 2 of epithelial tumors of ovary) C56 C56 8933, 8950-895, 8980 8950, 8980 3 Adenosarcoma C56 8933 R 2 Sex cord tumours of ovary C56 8600, 8620, 8630-863, 8634, 8640, 8650, 8670. 3 Granulosa cell tumour malignant C56 8620/3 3 Granulosa cell tumour malignant, adult type C56 3 Granulosa cell tumour malignant, juvenile type C56 3 Sertoli-Leydig cell tumour poorly differentiated C56 8620/ this is included in the list however it will not be included in the analyses because/ 8622/ this is included in the list however it will not be included in the analyses because/ 863 3 Steroid cell tumour, malignant C56 8670 R 2 Malignant/Immature teratomas of ovary C56 9080-9084, 9090, 902, 939, 9440, 9473, 950 3 Teratoma, malignant, NOS C56 9080 3 Struma ovarii, malignant C56 9090 3 Primitive neuroectodermal tumour, NOS C56 9473 3 Ependymoma C56 939 3 Medulloepithelioma, NOS C56 950 3 Glioblastoma C56 9440 R 2 Germ cell tumour of ovary C56 9060-9065, 9070-9072, 9085, 900-90 3 Dysgerminoma/Seminoma C56 9060-9065 3 Yolk sac tumour C56 907

3 Mixed germ cell tumour C56 9085 3 Embryonal adenocarcinoma C56 9070 3 Choriocarcinoma, NOS C56 900 3 Polyembryoma C56 9072 EPITHELIAL TUMOURS OF VULVA AND VAGINA C5, C52 R 2 Squamous cell carcinoma with variants of vulva and vagina C5, C52 8000, 800, 800, 80, 8020-8022, 8050-8084, 840-84, 843, 847, 890-82, 8230-823, 8255-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 8390-8420, 8430, 8480-8490, 8500, 8503-8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562-8576 8050-8084 R 2 Adenocarcinoma with variants of vulva and vagina C5, C52 840-84, 843, 847, 890-82, 8230-823, 8255-8263, 8290, 830, 835, 8320, 8323, 8333, 8380-8384, 8390-8420, 8430, 8480-8490, 8500, 8503-8504, 850, 852, 854, 8525, 8550-855, 8560, 8562-8576 R 2 Paget's disease of vulva and vagina C5, C52 8542 R 2 Undifferentiated carcinoma of vulva and vagina C5, C52 8020-8022 TROPHOBLASTIC TUMOUR OF PLACENTA C58.9 900, 905 R 2 Choriocarcinoma of placenta C58.9 900 EPITHELIAL TUMOURS OF PROSTATE C6, C637 2 Adenocarcinoma with variants of prostate C6 3 Adenocarcinoma NOS C6 8000-800, 8020-8022, 8032, 8050, 8070-8072, 8074, 8082, 820, 822-823, 830-83, 840-84, 843, 847, 890, 8200-820, 820-82, 8230-823, 8360, 8255, 8262-8263, 8290, 830, 8320, 8323, 8333, 8380-8384,8430, 8440, 8480-8490, 8500, 8503-8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562-8576 8032, 8074, 8082, 840-84, 843, 890, 820-82, 823, 8255, 8262-8263, 8290, 830, 8320, 8323, 8333, 8380-8384,8430, 8440, 8480-8490, 8504, 850, 852, 854, 8525, 8542, 8550-855, 8562-8576 840 3 Acinar cell adenocarcinoma C6 8550 3 Mucinous adenocarcinoma C6 8480-848 3 Signet ring cell carcinoma C6 8490

3 Adenocarcinoma with neuroendocrine differentiation C6 8574 3 Oxyphilic adenocarcinoma C6 8290 3 Spindle cell adenocarcinoma C6 8032, 8074, 8572 3 Lymphoepithelial carcinoma C6 8082 R 2 Squamous cell carcinoma with variants of prostate C6 8070-8072, 8560, 823 3 Squamous carcinoma C6 8070 3 Adenosquamous carcinoma C6 8560 3 Basaloid carcinoma C6 823 R 2 Infiltrating duct carcinoma of prostate C6 8050, 820, 8230, 8260, 8500, 8503 3 Cribriform carcinoma C6 820 3 Solid carcinoma, NOS C6 8230 3 Papillary adenocarcinoma, NOS C6 8050, 8260 R 2 Transitional cell carcinoma of prostate C6 820, 822, 830-83 R 2 Salivary gland type tumours of prostate C6 823, 847 and 8200 3 Adenoid cystic carcinoma C6 8200 3 Basal cell adenocarcinoma C6 847 TESTICULAR AND PARATESTICULAR CANCERS C62, C63.0, C63., C63.8 R 2 Paratesticular adenocarcinoma with variants C63.0, C63. 8000, 800,800,80, 820, 823, 840-84, 847, 890, 820-82, 822, 823, 8255, 8260, 826-8263, 8290, 830, 8320, 8323, 8333, 8380-8384, 840, 8430, 8440-844, 8470, 8480-8490, 8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562-8576, 8590, 8630-8640, 8650, 8670, 9060-902 820, 823, 840-84, 847, 890, 8200, 820-82, 822, 8230, 823, 8255, 8260, 826-8263, 8290, 830, 8320, 8323, 8333, 8380-8384, 840, 8430, 8440-844, 8470, 8480-8490, 8504, 850, 852, 854, 8525, 8542, 8550-855, 8560, 8562-8576

3 Endometrioid adenocarcinoma, NOS C63.0, C63. 8380 3 Clear cell adenocarcinoma, NOS C63.0, C63. 830 3 Serous cystadenocarcinoma, NOS C63.0, C63. 844 3 Mucinous cystadenocarcinoma, NOS C63.0, C63. 8470 3 Collecting duct and rete testis carcinoma C63.0, C63. malignancy without ICD-O morphology code 3 Transitional cell carcinoma, NOS C63.0, C63. 820 R 2 Non seminomatous testicular cancer C62 9080-9083, 9085, 900-902, 9065, 9070-9072 3 Mixed germ cell tumour C62 9085 3 Teratocarcinoma C62 908 3 Choriocarcinoma combined with other germ cell elements C62 90 3 Embryonal adenocarcinoma, NOS C62 9070 3 Yolk sac tumour C62 907 3 Choriocarcinoma, NOS C62 900 R 2 Seminomatous testicular cancer C62 9060-9062 3 Seminoma, NOS C62 906 R 2 Spermatocytic seminoma C62 9063 R 2 Teratoma with malignant transformation C62 9084 R 2 Testicular sex cord cancer C62 8630-8640, 8650, 8590-8592 3 Leydig cell tumour malignant C62 8650 3 Sertoli cell carcinoma C62 8640

3 Malignant sex cord/gonadal stromal tumours C62 8590-8592 borderline malignancy EPITHELIAL TUMOURS OF PENIS C60 R 2 Squamous cell carcinoma with variants of penis C60 8000-800, 800-80, 8020-8022, 8050-8084, 8090, 8094, 820-82, 823, 830, 840, 847, 890, 8200-820, 820-82, 822, 8230-823, 8255-8263, 8290, 830, 8320, 8323, 8333, 840, 8430-8440, 8480-8490,8504, 850, 852, 854, 8525, 8542, 8550-855, 8560-8576, 8940 8020-8022, 8050-8084, 823 3 Squamous carcinoma C60 8070 3 Adenosquamous carcinoma C60 8560 3 Verrocous carcinoma C60 805 3 Squamous cell carcinoma, sarcomatoid C60 8074 3 Basaloid carcinoma C60 823 R 2 Adenocarcinoma with variants of penis C60 3 Extramammary Paget's disease C60 840-84, 847, 890, 8200-820, 820-82, 8230-823, 8255-8263, 830, 8323, 8440, 8480-8490, 8504, 850, 852, 854, 8525, 8542, 8550-8576, 8940 8542 3 Sebaceous adenocarcinoma C60 840 3 Papillary adenocarcinoma, NOS C60 8260 3 Mixed tumour malignant, NOS C60 8940 3 Clear cell adenocarcinoma, NOS C60 830 3 Basal cell adenocarcinoma C60 847 EPITELIAL TUMOURS OF KIDNEY C64 2 Renal cell carcinoma with variants C64 8000-800, 800-80, 8020, 8022, 8030-8035, 8050-8084, 8090, 8094, 820, 822, 823, 830-83, 840-84, 843, 847, 890, 8200, 820, 820-82, 822, 8230-823, 8255-8263, 8290, 830, 832, 835-8320, 8323, 8333, 8380-8384, 840, 8430, 8440, 8480-8490, 8503-8504, 850-852, 854, 8525, 8542, 8550-855, 8560-8576, 8980 8050, 840-84, 843, 847, 890, 8200, 820, 82, 822, 8230-823, 8255-8263, 8290, 830, 832, 835-8320, 8323, 8333, 840, 8430, 8440, 8480-8490, 8503-8504, 850-852, 854, 8525, 8542, 8550-855, 8562

3 Adenocarcinoma NOS C64 840 3 Renal cell adenocarcinoma C64 832 3 Clear cell adenocarcinoma, NOS C64 830 3 Papillary adenocarcinoma, NOS C64 8050, 8260 3 Renal cell carcinoma chromophobe type C64 837 3 Collecting duct carcinoma C64 839 3 Xp translocation carcinoma C64 malignancy without ICD-O morphology code 3 Carcinoma associated with neuroblastoma C64 malignancy without ICD-O morphology code 3 Renal medullary carcinoma C64 850 3 Mucinous tubular and spindle cell carcinoma C64 malignancy without ICD-O morphology code R 2 Squamous cell carcinoma spindle cell type of kidney R 2 Squamous cell carcinoma with variants of kidney EPITHELIAL TUMOURS OF PELVIS AND URETER AND URETHRA C64 C64 C65.9,C66.9,C68.0 8032, 8074, 8980 8020-8022, 805-8073, 8075-8084, 8560 8000-800, 800-80, 8020, 8022, 803, 8050-8084, 8090, 8094, 820, 822, 823, 830-83, 840-84, 843, 847, 890, 8200, 820, 820-82, 822, 8230-823, 8255-8263, 8290, 830, 8320, 8323, 8333, 840, 8430 8440, 8480-8490, 8504, 850, 852, 854, 8525, 8542, 8550-855, 8560-8576 R 2 Transitional cell carcinoma of pelvis and ureter and urethra C65.9,C66.9,C68.0 8020-8022, 803, 8050 8082, 820, 822, 830-83 3 Undifferentiated carcinoma C65.9,C66.9,C68.0 8020-8022 3 Transitional cell carcinoma spindle cell C65.9,C66.9,C68.0 822 3 Lymphoepithelioma-like carcinoma C65.9,C66.9,C68.0 8082 3 Transitional cell carcinoma, giant cell C65.9,C66.9,C68.0 803

3 Transitional cell carcinoma, micropapillary C65.9,C66.9,C68.0 83 R 2 Squamous cell carcinoma with variants of pelvis and ureter and urethra C65.9,C66.9,C68.0 805-8076; 823 3 Basaloid carcinoma C65.9,C66.9,C68.0 823 3 Verrucous carcinoma C65.9,C66.9,C68.0 805 R 2 Adenocarcinoma with variants of pelvis and ureter and urethra C65.9,C66.9,C68.0 3 Mucinous adenocarcinoma C65.9,C66.9,C68.0 840-84, 843, 847, 890, 8200, 820, 82, 822, 8230-823, 8255, 8260-8263, 8290, 830, 8320, 8323, 8430, 8480-8490, 850, 852, 854, 8525, 8542, 8560, 8570 8480-848 3 Clear cell adenocarcinoma, NOS C65.9,C66.9,C68.0 830 3 Signet ring cell carcinoma C65.9,C66.9,C68.0 8490 3 Adenoid cystic carcinoma C65.9,C66.9,C68.0 8200 R 2 Salivary gland-type tumours of pelvis, ureter and urethra C65.9,C66.9,C68.0 823, 8200, 8430 3 Basaloid carcinoma C65.9,C66.9,C68.0 823 3 Adenoid cystic carcinoma C65.9,C66.9,C68.0 8200 3 Mucoepidermoid carcinoma C68.0 8430 EPITHELIAL TUMOURS OF URETHRA C68.0 R 2 Transitional cell carcinoma of urethra C68.0 8000-800, 800-80, 8020, 8022, 803, 8050-8084, 8090, 8094, 820, 822, 823, 830-83, 840-84, 843, 847, 890, 8200, 820, 820-82, 822, 8230-823, 8255-8263, 8290, 830, 8320, 8323, 8333, 840, 8440, 8480-8490, 8504, 850, 852, 854, 8525, 8542, 8550-855, 8560-8576 8020-8022, 803, 8050, 8082, 820, 822, 830-83 3 Undifferentiated carcinoma C68.0 8020-8022 3 Transitional cell carcinoma spindle cell C68.0 822 3 Lymphoepithelioma-like carcinoma C68.0 8082

3 Transitional cell carcinoma, giant cell C68.0 803 3 Transitional cell carcinoma, micropapillary C68.0 83 R 2 Squamous cell carcinoma with variants of urethra C68.0 805-8076; 823 3 Basaloid carcinoma C68.0 823 3 Verrucous carcinoma C68.0 805 R 2 Adenocarcinoma with variants of urethra C68.0 3 Mucinous adenocarcinoma C68.0 840-84, 843, 847, 890, 8200-820, 82, 822, 8230-823, 8255, 8260-8263, 8290, 830, 8320, 8323, 8430, 8480-8490, 850, 852, 854, 8525, 8542, 8560, 8570 8480-848 3 Clear cell adenocarcinoma, NOS C68.0 830 3 Signet ring cell carcinoma C68.0 8490 3 Adenoid cystic carcinoma C68.0 8200 EPITHELIAL TUMOURS OF BLADDER C67 2 Transitional cell carcinoma of bladder C67 8000-800, 800-80, 8020, 8022, 803, 8050-8084, 8090, 8094, 820, 822, 823, 830-83, 840-84, 843, 847, 890, 8200, 820, 820-82, 822, 8230-823, 8255-8263, 8290, 830, 8320, 8323, 8333, 840, 8430-8440, 8480-8490, 8504, 850, 852, 854, 8525, 8542, 8550-855, 8560-8576 8020-8022, 803, 8050, 8082, 820, 822, 830-83 3 Undifferentiated carcinoma C67 8020-8022 3 Transitional cell carcinoma spindle cell C67 822 3 Transitional cell carcinoma with squamous differentiation C67 malignancy without ICD-O morphology code 3 Lymphoepithelial carcinoma C67 8082 3 Giant cell carcinoma C67 803 3 Transitional cell carcinoma micropapillary C67 83 R 2 Squamous cell carcinoma with variants of bladder C67 805-8076; 823

3 Basaloid carcinoma C67 823 3 Verrucous carcinoma C67 805 R 2 Adenocarcinoma with variants of bladder C67 3 Mucinous adenocarcinoma C67 840-84, 843, 847, 890, 820, 82, 822, 8230-823, 8255, 8260-8263, 8290, 830, 8320, 8323, 8480-8490, 850, 852, 854, 8525, 8542, 8560, 8570 8480-848 3 Clear cell adenocarcinoma, NOS C67 830 3 Signet ring cell carcinoma C67 8490 R 2 Salivary gland type tumours of bladder C67 823, 8200, 8430 3 Basaloid carcinoma C67 823 3 Adenoid cystic carcinoma C67 8200 3 Mucoepidermoid carcinoma C67 8430 EPITHELIAL TUMOURS OF EYE AND ADNEXA C69.0, C69.5 8000-800, 800-80, 8020, 8050-8084, 8090, 8094, 820-82, 823, 830, 840-84, 847, 890, 820-82, 8200-820, 822, 8230-823, 8255-8263, 8290, 830, 8320, 8323, 8333, 840, 8430-8440, 8480-8490, 8504, 850, 852, 854, 8525, 8542, 8550-855, 8560-8576 R 2 Squamous cell carcinoma with variants of eye and adnexa C69.0, C69.5 8020, 8050-8082, 8090 3 Squamous carcinoma C69.0, C69.5 8070 3 Basal cell carcinoma C69.0, C69.5 8090 R 2 Adenocarcinoma with variants of eye and adnexa C69.0, C69.5 3 Adenocarcinoma NOS C69.0, C69.5 840, 847, 890, 8200, 822, 8230-823, 8255-8263, 8290, 830, 8320, 8323, 840, 8430-8440, 8480-8490, 850, 852, 854, 8525, 8542, 8550-855, 8560-8576 840 3 Adenoid cystic carcinoma C69.0, C69.5 8200 3 Mucoepidermoid carcinoma C69.0, C69.5 8430

EPITHELIAL TUMOURS OF MIDDLE EAR C30. 8000-800, 800-80, 8020, 8050-8084, 8090, 8094, 820-82, 823, 830, 840-84, 847, 890, 8200-820, 820-82, 822, 8230-823, 8255-8263, 8290, 830, 8320, 8323, 8333, 840, 8430-8440, 8480-8490, 8504, 850, 852, 854, 8525, 8542, 8550-855, 8560-8576 R 2 Squamous cell carcinoma with variants middle ear C30. 8050-8084, 8090, 8094, 820, 82, 823, 830 3 Squamous carcinoma C30. 8070 R 2 Adenocarcinoma with variants of middle ear C30. 3 Adenocarcinoma NOS C30. 840, 847, 890, 8200, 822, 8230-823, 8255-8263, 8290, 830, 8320, 8323, 840, 8430-8440, 8480-8490, 850, 852, 854, 8525, 8542, 8550-855, 8560-8576 840 3 Adenoid cystic carcinoma C30. 8200 MALIGNANT MESOTHELIOMA all cancer sites 9050-9053 R 2 Mesothelioma of pleura and pericardium C38 9050-9053 3 Epithelioid malignant mesothelioma C38 9052 3 Sarcomatoid malignant mesothelioma C38 905 R 2 Mesothelioma of peritoneum and tunica vaginalis C48, C63.7 9050-9053 3 Epithelioid malignant mesothelioma C48, C63.7 9052 3 Sarcomatoid malignant mesothelioma C48, C63.7 905 MALIGNANT SKIN MELANOMA C44 8720-8780 3 Superficial spreading melanoma C44 8743 3 Nodular melanoma C44 872 3 Lentigo maligna melanoma C44 8742 3 Acral lentiginous melanoma malignant C44 8744 R MALIGNANT MELANOMA OF MUCOSA C00-C26, C30-C34, C52, C65-C68 8720-8780

R MALIGNANT MELANOMA OF UVEA C69.3-C69.4 8720-8780 EPITHELIAL TUMOURS OF SKIN C44, C63.2 80, 8032, 8050-8052, 8070-8078, 8090-8098, 8560 2 Basal cell carcinoma of skin C44, C63.2 8090-8098 3 Basal cell carcinoma NOS C44, C63.2 8090, 8092 3 Basosquamous carcinoma C44, C63.2 8094 3 Multifocal superficial basal cell carcinoma C44, C63.2 809 3 Basal cell carcinoma nodular C44, C63.2 8097 3 Basal cell carcinoma fibroepithelial C44, C63.2 8093 3 Adenoid basal carcinoma C44, C63.2 8098 2 Squamous cell carcinoma with variants of skin C44, C63.2 80, 8032, 8050-8052, 8070-8078, 8560 3 Squamous carcinoma C44, C63.2 8070 3 Verrucous carcinoma C44, C63.2 805 3 Spindle cell carcinoma C44, C63.2 8032, 8074 3 Pseudo vascular/ Squamous cell carcinoma adenoid C44, C63.2 8075 3 Adenosquamous carcinoma C44, C63.2 8560 R ADNEXAL CARCINOMA OF SKIN C44, C63.2 800-80, 8200, 82, 8390-8420, 8480-848, 8542, 8940 3 Nodular hidradenoma, malignant C44, C63.2 8402 3 Sebaceous adenocarcinoma C44, C63.2 840 3 Adenoid cystic carcinoma C44, C63.2 8200 3 Paget's disease extramammary C44, C63.2 8542

3 Apocrine adenocarcinoma C44, C63.2 840 3 Mucinous adenocarcinoma C44, C63.2 8480-848 3 Pilomatrix carcinoma C44, C63.2 80 3 Eccrine poroma, malignant C44, C63.2 8409 3 Mixed tumour malignant, NOS C44, C63.2 8940 3 Sclerosing sweat duct carcinoma C44, C63.2 8407 3 Malignant eccrine spiradenoma C44, C63.2 8403 3 Tubular adenocarcinoma C44, C63.2 82 3 Eccrine papillary adenocarcinoma C44, C63.2 8408 EMBRYONAL NEOPLASMS all cancers sites, except CNS and ANS and peripheral nerves 8960, 8970-8973, 9490, 9500, 950-954 R (2) NEUROBLASTOMA AND GANGLIONEUROBLASTOMA R (2) NEPHROBLASTOMA C64.9 all cancers sites, except CNS and ANS and peripheral nerves 9490, 9500 8960 R (2) RETINOBLASTOMA C69.2 950-954 R (2) HEPATOBLASTOMA C22.0 8970 R (2) PLEUROPULMONARY BLASTOMA C34 8973 R (2) PANCREATOBLASTOMA C25 897 R OLFACTORY NEUROBLASTOMA C30.0-C3.9 9520, 9522, 9523 EXTRAGONADAL GERM CELL TUMOURS all cancers sites except C56, C58 and C62 9070, 907, 908, 9084, 9085, 900,90 R 2 Non seminomatous germ cell tumours all cancer sites except C56, C58, C62, C7-C72, C75., C75.3 9060-9063,9070, 907, 908, 9084, 9085, 900,90

3 Embryonal adenocarcinoma, NOS all cancer sites except C56, C58, C62, C7-C72, C75., C75.3 3 Yolk sac tumour all cancer sites except C56, C58, C62, C7-C72, C75., C75.3 3 Teratocarcinoma all cancer sites except C56, C58, C62, C7-C72, C75., C75.3 2 Teratoma with malignant transformation all cancer sites except C56, C58, C62, C7-C72, C75., C75.3 3 Mixed germ cell tumour all cancer sites except C56, C58, C62, C7-C72, C75., C75.3 3 Choriocarcinoma, NOS all cancer sites except C56, C58, C62, C7-C72, C75., C75.3 3 Choriocarcinoma combined with other germ cell elements all cancer sites except C56, C58, C62, C7-C72, C75., C75.3 2 Seminomatous germ cell tumors all cancer sites except C56, C58, C62, C7-C72, C75., C75.3 3 Dysgerminoma all cancer sites except C56, C58, C62, C7-C72, C75., C75.3 3 Seminoma, NOS all cancer sites except C56, C58, C62, C7-C72, C75., C75.3 3 Seminoma, anaplstic all cancer sites except C56, C58, C62, C7-C72, C75., C75.3 3 Spermatocytic seminoma all cancer sites except C56, C58, C62, C7-C72, C75., C75.3 2 Germ cell tumors of CNS C7-C72, C75., C75.3 9070 907 908 9084 9085 900 90 9060-9063 9060 906 9062 9063 9060-9063, 9070, 907, 908, 9084, 9085, 900,90 3 Dysgerminoma C7-C72, C75., C75.3 9060 3 Seminoma, NOS C7-C72, C75., C75.3 906 3 Seminoma, anaplastic C7-C72, C75., C75.3 9062 3 Spermatocytic seminoma C7-C72, C75., C75.3 9063 3 Embryonal adenocarcinoma, NOS C7-C72, C75., C75.3 9070 3 Yolk sac tumour C7-C72, C75., C75.3 907 3 Teratocarcinoma C7-C72, C75., C75.3 908

3 Teratoma with malignant transformation C7-C72, C75., C75.3 9084 3 Mixed germ cell tumour C7-C72, C75., C75.3 9085 3 Choriocarcinoma, NOS C7-C72, C75., C75.3 900 3 Choriocarcinoma combined with other germ cell elements C7-C72, C75., C75.3 90

SOFT TISSUE SARCOMA all cancers sites except C40.0-C4.9 8800-8935, 8940, 8950-8959, 8963-8964, 8990-899, 9020-9044, 920-933, 950, 970, 980, 923, 9240, 925, 9364-9365, 9370, 937-9372, 9540, 9560-957, 9580-958 (includes sarcoma of unknown primary sites) R 2 Soft tissue sarcoma of head and neck C00.0-C4.8, C30.0-C32.9, C49.0, C73.9, C75.2, C75.4, C76.0 8800-8902, 892, 892, 8933-8935, 8963, 8990-899, 9040-9044, 920-933, 950, 970, 980, 923, 9240,9364-9365, 9370, 937-9372, 9540, 9560-957, 9580-958. 3 Sarcoma NOS C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C75.4 3 Epithelioid sarcoma C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C75.4 3 Desmoplastic small round cell tumour C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C75.4 3 Fibrosarcoma C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C75.4 3 Fibromyxosarcoma C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C75.4 3 Infantile fibrosarcoma C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C75.4 3 Myxoinflammatory fibroblastic sarcoma C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C75.4 3 Malignant fibrous histiocytoma C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C75.4 3 DFSP C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C75.4 3 Well differentiated liposarcoma C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C75.4 3 Myxoid liposarcoma C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C75.4 3 Pleomorphic liposarcoma C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C75.4 3 Mixed type liposarcoma C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C75.4 3 Dedifferentiated liposarcoma C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C75.4 3 Leiomyosarcoma C00.0-C4.8, C30.0, C3.0- C32.9, C47.0, C49.0, C73.9, C75.2, C75.4 8800 8804 8806 880 88 884 8825. borderline malignancy 8830 8832-8833 885 8852 8854 8855 8858 8890